Brief: Paion: Mundipharma Gets Market Approval For Anerem In General Anesthesia In Japan
Jan 23 (Reuters) - Paion AG PA8G.DE :
* MUNDIPHARMA RECEIVES MARKET APPROVAL FOR ANEREM(R)
(REMIMAZOLAM)
IN GENERAL ANESTHESIA IN JAPAN
* NDA APPROVAL OF REMIMAZOLAM IN JAPAN WILL TRIGGER
MILESTONE
PAYMENTS
* MILESTONE PAYMENTS BETWEEN EUR 1.5 MILLION AND EUR 2.5
MILLION
COMING FROM MUNDIPHARMA AND HANA PHARM
Source text for Eikon: ID:nEQ4XBMMNa
Further company coverage: PA8G.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on PAION AG
See all newsBrief: Paion AG To Issue Approx 4.8 Mln Shares In Capital Increase With Subscription Rights
Brief: Paion AG Reports Developments On Commercial Activities In Europe
Brief: Paion Q1 EBITDA Up At EUR 15 Mln
Brief: Paion Grants Exclusive License To Cristália For Development And Commercialization Of Remimazolam In Latin America
Brief: Paion Announces Sebastian Werner As New CFO, Effective 1 June 2022